肺动脉高压与肺静脉闭塞病和/或肺毛细血管瘤病在双能CT肺灌注特征上的初步经验:63例患者研究
研究比较了63例特发性或遗传性肺动脉高压(A组51例)与肺静脉闭塞病和/或肺毛细血管瘤病(B组12例)患者的双能CT肺灌注特征,发现两组异常灌注患者比例及人均异常灌注肺段数无显著差异,但B组人均PE型灌注缺陷肺段百分比中位数显著高于A组。
要点
- PAH组最常见的灌注异常为斑片状缺陷(15/35,42.9%)。
- PVOD/PCH组表现为多种灌注异常的不同组合(4/6,66.7%)。
- PVOD/PCH组人均PE型缺陷肺段百分比中位数显著高于PAH组(p=0.041)。
核心结论
- 两组灌注异常无显著差异,仅PVOD/PCH组人均PE型缺陷肺段百分比中位数显著高于PAH组。
研究设计与样本
- 回顾性分析63例特发性或遗传性PAH(A组,n=51)与PVOD/PCH(B组,n=12)患者,行双能CT血管成像并重建形态学与灌注图像。
关键影像表现/征象
- PAH组最常见表现为斑片状灌注缺陷(15/35,42.9%)。
- PVOD/PCH组表现为多种灌注异常的不同组合(4/6,66.7%)。
- 8例患者(A组5/51,9.8%;B组3/12,25%)出现两种PE型缺陷,叠加于PH相关肺部异常(7/8)或正常肺(1/8)。
诊断标准与关键数值
- 异常灌注患者比例:A组35/51(68.6%) vs B组6/12(50%),p=0.31。
- 人均异常灌注肺段数:A组17.9±4.9 vs B组18.3±4.1,p=0.91。
- 人均PE型缺陷肺段百分比中位数:B组显著高于A组(p=0.041)。
- 灌注异常患者碘浓度显著更低(p<0.001),但两组间无差异。
临床应用与阅片要点
- 双能CT可显示PAH与PVOD/PCH的灌注异常,包括斑片状及PE型缺陷。
- PVOD/PCH患者PE型缺陷肺段百分比中位数更高,可能有助于鉴别。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: In the stratification of potential causes of PH, current guidelines recommend performing V/Q lung scintigraphy to screen for CTEPH. The recognition of CTEPH is based on the identification of lung segments or sub-segments without perfusion but preserved ventilation. The presence of mismatched perfusion defects has also been described in a small proportion of idiopathic pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH). Dual-energy CT lung perfusion changes have not been specifically investigated in these two entities.
PURPOSE: To compare dual-energy CT (DECT) perfusion characteristics in PAH and PVOD/PCH, with specific interest in PE-type perfusion defects.
MATERIALS AND METHODS: Sixty-three patients with idiopathic or heritable PAH (group A; n = 51) and PVOD/PCH (group B; n = 12) were investigated with DECT angiography with reconstruction of morphologic and perfusion images.
RESULTS: The number of patients with abnormal perfusion did not differ between group A (35/51; 68.6%) and group B (6/12; 50%) (p = 0.31) nor did the mean number of segments with abnormal perfusion per patient (group A: 17.9 ± 4.9; group B: 18.3 ± 4.1; p = 0.91). The most frequent finding was the presence of patchy defects in group A (15/35; 42.9%) and a variable association of perfusion abnormalities in group B (4/6; 66.7%). The median percentage of segments with PE-type defects per patient was significantly higher in group B than in group A (p = 0.041). Two types of PE-type defects were depicted in 8 patients (group A: 5/51; 9.8%; group B: 3/12; 25%), superimposed on PH-related lung abnormalities (7/8) or normal lung (1/8). The iodine concentration was significantly lower in patients with abnormal perfusion (p < 0.001) but did not differ between groups.
CONCLUSION: Perfusion abnormalities did not differ between the two groups at the exception of a higher median percentage of segments with PE-type defects in patients with PVOD/PCH.
KEY POINTS: • Patchy perfusion defect was the most frequent pattern in PAH. • A variable association of perfusion abnormalities was seen in PVOD/PCH. • Lobular and PE-type perfusion defects larger than a sub-segment were depicted in both PAH and PVOD/PCH patients.
引用
- Lefebvre, Kyheng, Giordano, et al. Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH): preliminary experience in 63 patients. Eur Radiol. 2022. PMID: 35286410. doi:10.1007/s00330-022-08577-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。